Rise and fall of hypofractionation in clinical radiotherapy in the 20th century;Rozkwit i upadek hipofrakcjonowania w radioterapii klinicznej XX wieku

Nowotwory

Volumn 57, Issue 4, 2007, Pages 359-369

  Friberg, Sten ^a,b   Rudén, Bengt Inge ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE   (Sweden)

Author keywords

Hypofractionation; Radiation complications; Radiation therapy

Indexed keywords

HISTORY OF MEDICINE; INJURY; MATHEMATICAL ANALYSIS; PHILOSOPHY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; SCIENTIST;

EID: 35348906701     PISSN: 0029540X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Freund L. Ein mit Roentgenstrahleu behandelter Fall von Naevus pigmentosus piliferous. Wein Med Wochenschr 1897; 47: 428-34.
2. Stenbäck T. Fall av hudkräfta, läkt med behandling av röntgenstrålar. HYGIEA 1900 ("Case of skin cancer cured by treatment with X-rays", our translation).
3. Sjögren T. Beitrag zum Therapeutischen Verwerthung der Röntgenstrahlen. Fortschr Roentgenstr 1900-1901.
4. Schwarzschild K. On the deviations from the law of reciprocity for bromide of silver gelatine. Astrophys J 1900;11:89-91.
5. Strandqvist M. Studien über die Cumulative Wirkung der Röntgenstrahlen bei Fraktionierung, Erfahrungen aus dem Radiumhemmet an 280 Haut- und Lippencarzinomen. Acta Radiol (Suppl) 1944; 55: 1-300.
6. Cohen L. Clinical radiation dosage I. Brit J Radiol 1949; 22: 160.
7. Ellis F. The relationship of biological effect to dose-time fractionation factors in radiotherapy. W: Ebert M and Howard A (red.) Current Topics in Radiation Research. 1968.
8. Kirk J, Gray WM, Watson ER. Cumulative radiation effect. Part 1: Fractionated treatment regimes. Clin Radiol 1971; 22: 145-53.
9. Hall EJ, Amato JG. Radiobiology for the radiologist. Wyd 6. Philadelphia Lippincott Williams & Wilkins, 2006.
10. Kim JJ and Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Rev 2005; 5: 516-25.
11. Sinclair WK. The shape of radiation survival curves of mammalian cells cultured in vitro. W: Biophysical aspects of radiation quality. IAEA, Vienna, Technical Reports Series 1966; 58. (IAEA = International Atomic Energy Agency).
12. Kellerer AM, Rossi HH. A generalized formulation of dual radiation action. Radiat Res 1978; 75: 471-88.
13. Travis EL, Tucker SL. Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol boil Phys 1987; 13: 283-7.
14. Van de Geijn. Incorporating the time factor into the linear-quadratic model (letter). Brit J Radiol 1989; 62: 296-8.
15. Fowler JF. Review article. The linear-quadratic formula and progress in fractionated radiotherapy: a review. Brit J Radiol 1989; 62: 679-94.
16. Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Brit J Radiol 1973; 46: 381-7.
17. Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction I. Comparison of effects of daily and once-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984a; 10: 593-8.
18. Turesson I, Notter G. The influence of the overall treatment time in radiotherapy on the acute reaction: Comparison of the effects of daily and twice-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984b; 10: 607-19.
19. Thames HD, Hendry JH. Fractionation in radiotherapy. London: Taylor & Francis; 1987.
20. Fowler JF. Final comments on Rome Symposium on the biological bases of tumor radioresistance. Int J Radiat Oncol Biol Phys 1978; 8: 115-6.
21. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
22. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457-67.
23. Hendry JH, Bentzen SM, Dale RG i wsp. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (Roy Coll Radiol) 1996; 8: 297-307.
24. Fowler JF. Review article: The linear-quadratic formula and progress in fractionated radiotherapy: a review. Brit J Radiol 1989; 62: 679-94.
25. Cox JD. Large-dose fractionation. Cancer 1985; 55: 2105-11.
26. Fletcher in his Regaud lecture in 1988: Perspectives on the history of radiotherapy. Radiother Oncol 1988; 12: 253-71.
27. Stoll BA and Andrews JT. Radiation-induced peripheral neuropathy. Brit Med J 1966; 1: 834-7.
28. Montague ED. Experience with altered fractionation in radiation therapy of breast cancer. Radiol 1968; 90: 962-6.
29. Overgaard M, Bentzen SM, Juul Christensen J i wsp. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 1987; 9: 1-12.
30. Bentzen SM. Steepness of the radiation dose-response for dose-per-fraction escalation keeping the number of fractions fixed. Acta Oncol 2005; 44: 825-28.
31. Reisner A. Hauterythem und Röntgenbestrahlung. Erg Med Strahlenforsch 1933; 6: 1-60.
32. Scholz W. Experimentelle Untersuchungen über die Einwirkung von Röntgenstrahlen auf das reife Gehirn. Z des Neurol Psychiat 1934; 150: 765.
33. Scholz W. Über die Empfindlichkeit des Gehirn für Röntgen- und Radiumstrahlen. Klin Wschr 1935; 14: 189.
34. Meischer G. Tierexperimentelle Untersuchungen über den Einfluss der Fraktionierung auf den Späteffekt. Acta Radiol 1935; 16: 25-38.
35. Holthusen H. Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlentherapie 1936; 57: 254-69.
36. Wülers H, Beck-Bornholt H-P. Origins of radiotherapy and radiobiology: separation of the influence of dose per fraction and overall treatment time on normal tissue damage by Reisner and Miescher in the 1930's. Radiother Oncol 1996; 38: 171-3.
37. Berry RJ, Wiernik G, Patterson RJS, Hopewell JW. Excess late subcutaneous fibrosis after irradiation of pig skin consequent upon the application of the NSD formula. Brit J Radiol 1974; 47: 277-81.
38. Withers HR, Thames HD i wsp. The relationship of acute and late skin injury in 2 and 5 fractions/week in γ-ray therapy. Int J Radiat Oncol Biol Phys 1978; 4: 595-601.
39. del Regato JA. Historical changes and time-dose relationship in therapeutic radiology. Front Radiat Ther Oncol 1968; 3: 1-5.
40. Buschke. In: the Janeway lecture in 1969. Radiation therapy: the past, the present, the future. Am J Roentgenol 1970; 108: 236-46.
41. Perthes G. Über die Behandlung des Karzinomas mit Röntgenstrahlen und über den Einfluss der Röntgenstrahlen auf die Zellteilung. Münchener Med Wochenschr 1904; 51: 282.
42. Pusey WA, Caldwell EW. Practical application of the Roentgen rays in therapeutics and diagnosis. Philadelphia: WB Saunders & Co; 1903.
43. Regaud C. Influence de la durée d' irradiation sur les effects determines dans le testicule par le Radium. C R Soc Biol 1922; 86: 787-90.
44. Coutard H. Roentgentherapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. Amer J Roentgenol 1932; 28: 313-31.
45. Seitz A and Wintz H. Unsere Methode der Röntgentherapie und ihre Erfolge. Strahlentherapie Suppl 22.
46. Holfelder H. A comparison of surgical and radiological conceptions in relation to treatment of disease. Brit J Radiol 1932; 5: 39.
47. Pfahler GE. The saturation method in roentgenotherapy as applied to deep seated malignant disease. Am J Roentgenol 1925; 14: 36.
48. Wintz H. Die Einzeit Bestrahlung. Strahlenther 1937; 58: 545.
49. Schwartz G. Dauerbestrahlung mit täglichen kleinen Dos. Winer Med Wochenschr 1914a; 52.
50. Münchener M Wochenschr 1914b; 61: 317.
51. Krönig S and Friedrich W. Physikalische und biologische Grundlagen der Strahlentherapie. Strahlentherapie 1918 Suppl. 20.
52. Fowler JF. 40 year of radiobiology: its impact on radiotherapy. Phys Med Biol 1984; 29: 97-113.
53. Atkins HL. Massive dose technique in radiation therapy of inoperable carcinoma of the breast. Am J Roentgenol Radium Ther Nucl Med 1964; 91: 80-9.
54. Fletcher GH: Hyperfractionation: Lessons from complications. Radiother Oncol 1991; 20: 10-5.
55. Andreasson CN. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 2005; 44: 801-15.
56. Fletcher GH. Perspectives on the history of radiotherapy. Radiother Oncol 1988;12: 253-71.
57. Friberg S and Mattson S. On the growth rates of human malignant tumors. Implications for medical decision making. J Surg Oncol 1997; 65: 284-97.
58. Friberg S. On the growth rates of human malignant tumors. Implications for medical decision making. Nowotwory J Oncol 2005; 55: 1-22.
59. th May, 1998, by the Hon Mrs Justice Ebsworth.
60. Dische S, Joslin CAF, Miller QC at al. The breast radiation injury litigation and the clinical oncologist. Clin Oncol 1998; 10: 367-71.
61. Erstatningsutvalget for stråleskader (In Norwegian). Sosial- og Helsedepartementet Oslo, 1999.
62. Friberg S and Rudén BI. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Part I. Manuscript in preparation.
63. Friberg S and Rudén BI. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Part II. Manuscript in preparation.
64. Fowler JF. Radiation biology as applied to radiotherapy. W: Ebert M and Howard A (red). Current Topics in Radiation Research North-Holland, Amsterdam 1966; 2: 303-64.
65. Johansson S. Late side-effects following radiotherapy after mastectomy in breast cancer patients. A long term follow up. Thesis 2000. Umeå University Medical Dissertations. ISBN 91-7191-877-9.
66. Galecki J, Hicer-Grenkowicz, Grudzien-Kowalska M i wsp. Radiation-induced brachial plexopathy and hyperfractionated regimens in adjuvant irradiation of patients with breast cancer - a review. Acta Oncol 2006; 45: 280-4.
67. Johansson S. Radiation induced brachial plexopathies. Acta Oncol 2006; 45: 253-7.
68. Cosset JM. The come-back of hypofractionation? Cancer Radiother 2005; 9: 266-73.
69. Goffman TE, Glatstein E. Hypofractionation redux. J Clin Oncol 2004; 22: 589-91.
70. Rades D, Walz J, Stalpers LJ i wsp. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. Europ Urol 2006; 49: 846-52.
71. Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951; 102: 316-9.
72. Wersäll DJ, Blomgren H, Lax I i wsp. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77: 88-95.
73. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (Stereotactic body radiation therapy) for oligometastases. Sem Radiat Oncol 2006; 16: 77-84.
74. Yin FF i wsp. Physics and imaging for targeting of oligometastases. Semin Radiat Oncol 2006; 16: 85-101.
75. Papers from SBRT 2006, the Third Acta Oncologica Symposium on Stereotactic Body Radiotherapy. Copenhagen, June, 2006. Acta Oncol 2006; 45: 771-994.
76. Bentzen SM, Overgaard J, Thames HD i wsp. Qincal radiobiology of malignant melanoma. Radiother Oncol 1989; 16: 169-82.
77. Reitan JB and Kaalhus O. Radiotherapy of liposarcomas. Brit J Radiol 1980; 53: 969-75.
78. Birgisson H, Talbäck M, Gunnarsson U i wsp. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845-53.
79. Alonzi HP, Hoskin P. Novel therapies in bladder cancer. Clin Oncol 2005; 17: 524-38.
80. Keish M, Vicini F. Applying innovations in surgical and radiation oncology in breast conservation therapy. Breast J 2005; 11: S24-9.
81. Fowler JF. Practical time-dose evaluations, or how to stop worrying and learn to love linear quadratics. W: Technical Basis of Radiation Therapy. Red.: Lewitt SH, Purdy JA, Perz CA, Vijayakumar S. Berlin, Heidelberg: Springer; 2006, 3-31.
82. Buckner CD. Intensity modulated radiation therapy. The Cancer Center 2005-1206.